756P First-in-human phase I study of a novel claudin 6 (CLDN6) targeted antibody drug conjugate (ADC) TORL-1-23

Autor: Konecny, G.E., Wahner Hendrickson, A.E., Winterhoff, B., Machado, A., Chander, C., Davenport, S., Bilic, S., Miller, L-L., Chung, A., Press, M.F., Letrent, S., Slamon, D.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S517-S517
Databáze: ScienceDirect